000 | 01780 a2200493 4500 | ||
---|---|---|---|
005 | 20250512025211.0 | ||
264 | 0 | _c19860606 | |
008 | 198606s 0 0 eng d | ||
022 | _a0733-2459 | ||
024 | 7 |
_a10.1002/jca.2920030211 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKiprov, D D | |
245 | 0 | 0 |
_aThe use of plasmapheresis, lymphocytapheresis, and staph protein-A immunoadsorption as an immunomodulatory therapy in patients with AIDS and AIDS-related conditions. _h[electronic resource] |
260 |
_bJournal of clinical apheresis _c1986 |
||
300 |
_a133-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _ximmunology |
650 | 0 | 4 |
_aAntibodies _xisolation & purification |
650 | 0 | 4 |
_aAntigen-Antibody Complex _xisolation & purification |
650 | 0 | 4 | _aBlood Component Removal |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunity, Cellular |
650 | 0 | 4 |
_aImmunosorbents _xtherapeutic use |
650 | 0 | 4 | _aLeukocyte Count |
650 | 0 | 4 | _aLymphocyte Transfusion |
650 | 0 | 4 |
_aLymphocytes _xcytology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPlasmapheresis |
650 | 0 | 4 |
_aSarcoma, Kaposi _xtherapy |
650 | 0 | 4 |
_aStaphylococcal Protein A _ximmunology |
650 | 0 | 4 |
_aSuppressor Factors, Immunologic _xisolation & purification |
650 | 0 | 4 |
_aT-Lymphocytes _xcytology |
650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _xcytology |
700 | 1 | _aLippert, R | |
700 | 1 | _aMiller, R G | |
700 | 1 | _aSandstrom, E | |
700 | 1 | _aJones, F R | |
700 | 1 | _aCohen, R J | |
700 | 1 | _aAbrams, D | |
700 | 1 | _aBusch, D F | |
773 | 0 |
_tJournal of clinical apheresis _gvol. 3 _gno. 2 _gp. 133-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jca.2920030211 _zAvailable from publisher's website |
999 |
_c2944908 _d2944908 |